LXEO EBITDA Growth

Lexeo Therapeutics Inc · EBITDA Growth

LXEO logo

LXEO EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported24.12%
LXEO TTM EBITDA YoY % (-10.83% → 24.12%)
High-resolution chart · PNG

LXEO ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Lexeo Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
24.1232%
20.4835%
-1.5406%
-21.5762%
-49.0528%
-59.07%
-49.4972%
-30.4001%
-21.426%
-5.7285%
-10.8302%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.